Cargando…

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1

OBJECTIVES: People living with HIV have increased Human Papillomavirus (HPV) related lesions and malignancies. We describe HPV DNA recovered from the cervix and anal canal, explore the effect of vaccination on HPV detection, and examine the durability of vaccine titers in women living with HIV-1 who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cespedes, Michelle S., Kang, Minhee, Kojic, Erna Milunka, Umbleja, Triin, Godfrey, Catherine, Webster-Cyriaque, Jennifer Y., Masih, Reena, Firnhaber, Cynthia, Grinsztejn, Beatriz, Saah, Alfred, Cu-Uvin, Susan, Aberg, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121154/ https://www.ncbi.nlm.nih.gov/pubmed/30118852 http://dx.doi.org/10.1016/j.pvr.2018.08.002

Ejemplares similares

Detection and quantitation of HPV in anogenital and oral tissues and fluids of HIV-positive individuals by real-time PCR
por: Seaman, William T, et al.
Publicado: (2010)

Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR
por: Seaman, William T, et al.
Publicado: (2010)

Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
por: Righolt, Christiaan H., et al.
Publicado: (2022)

Anogenital-Associated Papillomaviruses in Animals: Focusing on Bos taurus Papillomaviruses
por: Yamashita-Kawanishi, Nanako, et al.
Publicado: (2020)

HIV-2 diagnosis and quantification in high-risk patients
por: Chan, Philip A, et al.
Publicado: (2008)

Anal and cervical cytologic abnormalities among HIV-infected women in the era of HAART
por: Kojic, EM, et al.
Publicado: (2009)

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Publicado: (2010)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

Determinants of high-risk human papillomavirus infection in anogenital warts
por: Ozaydin-Yavuz, Goknur, et al.
Publicado: (2019)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Intralesional bivalent and quadrivalent human papillomavirus vaccines didn’t significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial
por: Fawzy, Manal, et al.
Publicado: (2023)

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
por: Murray, Macey L., et al.
Publicado: (2018)

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
por: Garland, Suzanne M., et al.
Publicado: (2016)

Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
por: Xu, Hui, et al.
Publicado: (2019)

Wide Spectrum Analysis of Human Papillomavirus Genotypes in External Anogenital Warts
por: Rideg, Orsolya, et al.
Publicado: (2021)

A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men
por: Ellsworth, G.B., et al.
Publicado: (2018)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

High Frequency of Human Papillomavirus Genotype 16 Among Patients With Anogenital Warts
por: Yaghoobi, Reza, et al.
Publicado: (2015)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

Identification of bovine papillomavirus type 1 and 2 from bovine anogenital fibropapillomas
por: YAMASHITA-KAWANISHI, Nanako, et al.
Publicado: (2019)

Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance
por: King, Eleanor M, et al.
Publicado: (2015)

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2021)

Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature
por: Chan, Philip A., et al.
Publicado: (2016)

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)

Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance
por: Gomes, Jéssica Menezes, et al.
Publicado: (2020)

Bacterial Vaginosis and the Natural History of Human Papillomavirus
por: King, Caroline C., et al.
Publicado: (2011)

Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men
por: Murenzi, Gad, et al.
Publicado: (2020)

Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis
por: Sasidharanpillai, Sabeena, et al.
Publicado: (2021)

Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)
por: Hernandez-Aguado, Juan J., et al.
Publicado: (2022)

A case of acute disseminated encephalomyelitis following human papillomavirus quadrivalent vaccination
por: Lee, Mina, et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

The causal role of human papillomavirus infections in non‐anogenital cancers. It's time to ask for the functional evidence.
por: von Knebel Döberitz, Magnus
Publicado: (2016)

Human papillomavirus infection with anogenital warts in a patient with chronic psoriasis: A case report
por: Hsieh, Wu‐Feng, et al.
Publicado: (2021)

Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models
por: Gunder, Laura C., et al.
Publicado: (2022)

Quantifying the broader economic consequences of quadrivalent human papillomavirus (HPV) vaccination in Germany applying a government perspective framework
por: Kotsopoulos, Nikolaos, et al.
Publicado: (2015)

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
por: Jit, Mark, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2unfukh098t4ld4qtbp0eviv28